New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics' PERLE Breast Implant

Contributed by: Business Wire

Logo

Tags

Surgery

Medical Devices

Other Health

Health

Clinical Trials

New Independent Clinical Study

More Like This

GC Aesthetics' PERLE™ Breast Implant features a proprietary surface technology (BioQ™) and GCA’s industry-leading gel technology (Emunomic™ Breast Tissue Dynamic Gel). (Photo: Business Wire)

GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants

GC Aesthetics® Launches YOUTHLY™: A New Era for Breast Implants in China

GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally

GC Aesthetics® Strengthens Board of Directors with Strategic Appointments

IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

Merz Aesthetics Presents New Data in the Field of Regenerative Aesthetics at the 2024 IMCAS World Congress